Stay updated on IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.3%
    Check dated 2025-09-14T00:42:26.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.3%
    Check dated 2025-09-06T21:17:19.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as the introduction of a new version for sacituzumab govitecan. However, many related topics and terms have been removed, which may affect the comprehensiveness of the content.
    Difference
    5%
    Check dated 2025-08-30T15:45:46.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T12:11:38.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-08-09T07:45:43.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    2%
    Check dated 2025-08-02T04:03:44.000Z thumbnail image

Stay in the know with updates to IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial page.